Loading…
This event has ended. Visit the official site or create your own event on Sched.

RL

Richard Lostritto

FDA
Acting Director, Office of Policy for Pharmaceutical Quality, OPQ, CDER
Richard (Rik) Lostritto currently serves as a Division Director In FDA's ONDQA. Prior to this, he served in the FDA as a Team Leader, and Chemsitry Reviewer.

My Chair Sessions

Monday, June 27
 

8:30am EDT

#115: Clinically Relevant Specifications: Translating Voice of the Patient Into Quality Attributes of the Product 111AB